The High Mobility Group (Hmg) Boxes of the Nuclear Protein Hmg1 Induce Chemotaxis and Cytoskeleton Reorganization in Rat Smooth Muscle Cells

HMG1 (high mobility group 1) is a ubiquitous and abundant chromatin component. However, HMG1 can be secreted by activated macrophages and monocytes, and can act as a mediator of inflammation and endotoxic lethality. Here we document a role of extracellular HMG1 in cell migration. HMG1 (and its individual DNA-binding domains) stimulated migration of rat smooth muscle cells in chemotaxis, chemokinesis, and wound healing assays. HMG1 induced rapid and transient changes of cell shape, and actin cytoskeleton reorganization leading to an elongated polarized morphology typical of motile cells. These effects were inhibited by antibodies directed against the receptor of advanced glycation endproducts, indicating that the receptor of advanced glycation endproducts is the receptor mediating the HMG1-dependent migratory responses. Pertussis toxin and the mitogen-activated protein kinase kinase inhibitor PD98059 also blocked HMG1-induced rat smooth muscle cell migration, suggesting that a Gi/o protein and mitogen-activated protein kinases are required for the HMG1 signaling pathway. We also show that HMG1 can be released by damage or necrosis of a variety of cell types, including endothelial cells. Thus, HMG1 has all the hallmarks of a molecule that can promote atherosclerosis and restenosis after vascular damage.

[1]  F. Blasi,et al.  Urokinase/urokinase receptor and vitronectin/αvβ3 integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways , 2001, Oncogene.

[2]  M. Beltrame,et al.  Upwardly mobile proteins , 2000, EMBO reports.

[3]  T. Kislinger,et al.  Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.

[4]  C. Murdoch,et al.  Chemokine receptors and their role in inflammation and infectious diseases. , 2000, Blood.

[5]  H. Huttunen,et al.  Regulation of cell migration by amphoterin. , 2000, Journal of cell science.

[6]  L. Dekker,et al.  Signals to Move Cells , 2000, Science.

[7]  R. Snyderman,et al.  Chemoattractant Receptors Activate Distinct Pathways for Chemotaxis and Secretion , 1999, The Journal of Biological Chemistry.

[8]  K. Tracey,et al.  Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. , 1999, Surgery.

[9]  Michael Bustin,et al.  Regulation of DNA-Dependent Activities by the Functional Motifs of the High-Mobility-Group Chromosomal Proteins , 1999, Molecular and Cellular Biology.

[10]  A. Villa,et al.  Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. , 1999, Blood.

[11]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[12]  H. Huttunen,et al.  Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways* , 1999, The Journal of Biological Chemistry.

[13]  A. Aguzzi,et al.  The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice , 1999, Nature Genetics.

[14]  M. Neurath,et al.  RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.

[15]  M. Torrisi,et al.  The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. , 1999, Molecular biology of the cell.

[16]  M. Gimbrone.  Vascular Endothelium , Hemodynamic Forces , and Atherogenesis , 1999 .

[17]  E. Brown,et al.  The Thrombospondin Receptor Integrin-associated Protein (CD47) Functionally Couples to Heterotrimeric Gi * , 1999, The Journal of Biological Chemistry.

[18]  A. Schmidt,et al.  Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. , 1999, Circulation research.

[19]  A. Schmidt,et al.  Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts , 1998, Nature Medicine.

[20]  E. Appella,et al.  A urokinase‐sensitive region of the human urokinase receptor is responsible for its chemotactic activity , 1997, The EMBO journal.

[21]  S. Schwartz.  Smooth muscle migration in atherosclerosis and restenosis. , 1997, The Journal of clinical investigation.

[22]  S. Schwartz.  Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis. , 1997, The Journal of clinical investigation.

[23]  G. Längst,et al.  High Mobility Group 1 Protein Is Not Stably Associated with the Chromosomes of Somatic Cells , 1997, The Journal of cell biology.

[24]  M. Bianchi,et al.  Recombinant HMG1 protein produced in Pichia pastoris: a nonviral gene delivery agent. , 1997, BioTechniques.

[25]  F. Jungalwala,et al.  Characterization of a Sulfoglucuronyl Carbohydrate Binding Protein in the Developing Nervous System , 1997, Journal of neurochemistry.

[26]  E. Melloni,et al.  Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation , 1997, FEBS letters.

[27]  E. Melloni,et al.  Extracellular high-mobility group 1 protein is essential for murine erythroleukaemia cell differentiation. , 1996, The Biochemical journal.

[28]  R. Leeuwen.  Extracellular proteolysis and the migrating vascular smooth muscle cell , 1996 .

[29]  E. Laue,et al.  Structure of the A-domain of HMG1 and its interaction with DNA as studied by heteronuclear three- and four-dimensional NMR spectroscopy. , 1995, Biochemistry.

[30]  J. Chen,et al.  The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin , 1995, The Journal of Biological Chemistry.

[31]  G. Bokoch.  Chemoattractant signaling and leukocyte activation. , 1995, Blood.

[32]  E. Neer.  Heterotrimeric C proteins: Organizers of transmembrane signals , 1995, Cell.

[33]  R. F. Cook,et al.  Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease , 1994, The Journal of cell biology.

[34]  A. Ridley.  Membrane ruffling and signal transduction , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[35]  Y. Zou,et al.  Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. , 1993, The American journal of pathology.

[36]  H. Rauvala,et al.  Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. , 1993, The Journal of biological chemistry.

[37]  P. Cary,et al.  Solution structure of a DNA-binding domain from HMG1. , 1993, Nucleic acids research.

[38]  P. Kraulis,et al.  Structure of the HMG box motif in the B‐domain of HMG1. , 1993, The EMBO journal.

[39]  K. O. Elliston,et al.  Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. , 1992, The Journal of biological chemistry.

[40]  H. Rauvala,et al.  Neurite growth-promoting protein (amphoterin, p30) binds syndecan. , 1992, Experimental cell research.

[41]  D. Lilley,et al.  The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. , 1992, The EMBO journal.

[42]  H. Rauvala,et al.  30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. , 1991, The Journal of biological chemistry.

[43]  H. Rauvala,et al.  Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. , 1991, The Journal of biological chemistry.

[44]  H. Rauvala,et al.  The adhesive and neurite-promoting molecule p30: analysis of the amino- terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons , 1988, The Journal of cell biology.

[45]  M. Bianchi,et al.  Interaction of a protein from rat liver nuclei with cruciform DNA. , 1988, The EMBO journal.

[46]  H. Schägger,et al.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.

[47]  F. Studier,et al.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. , 1986, Journal of molecular biology.

[48]  J. Parkkinen,et al.  Amphoterin, the 30-kDa Protein in a Family of HMGl-type Polypeptides , 2001 .

[49]  Interactions of Plasminogen and Tissue Plasminogen Activator ( tPA ) with Amphoterin , 2001 .

[50]  B. Dewald,et al.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.